Frontlight ResearchEarly access
CompletedNo phase
Different Norepinephrine Doses on Accuracy of Peripheral Perfusion Index in Predicting Tissue Perfusion in Septic Shock Patients
Key facts
- Who runs it
- Tanta University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 80 people enrolled
- Started
- 30 Oct 2024
- Ended
- 30 Mar 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- Group I: Patients will receive norepinephrine <0.15 µg/kg/min
- Group II: Patients will receive norepinephrine ≥ 0.15 µg/kg/min
- Record updated
- 9 January 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age 18 to 65 years
- Both sexes
- Septic shock patients requiring norepinephrine infusion at dose <0.25 µg/kg/min to achieve mean arterial pressure (Mean arterial blood pressure ≥ 65 mm Hg)
Who cannot take part
- Diabetes mellitus
- Respiratory diseases affecting gas exchange, such as asthma and Chronic Obstructive Pulmonary Disease
- Cardiovascular diseases and pulmonary edema
- Patients fail to achieve Mean arterial blood ≥ 65 mm Hg or need norepinephrine dose ≥0.25 µg /kg/min
- Pregnancy
- Tissue edema
- Sever hypoxemia or hypercarbia
- Core temperature < 36 ᴼc
- Body mass index ≥35 kg/m2
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to evaluate the impact of different norepinephrine doses on the accuracy of the peripheral perfusion index in predicting tissue perfusion in septic shock patients.
Read full original descriptionShow less
Primary outcome:
* Correlation between peripheral perfusion index
Secondary outcomes:
* Peripheral perfusion index accuracy to predict the tissue perfusion . * Peripheral perfusion index accuracy to predict mortality.
The 2 groups in the trial
- Group ITreatment being tested
Patients will receive norepinephrine \<0.15 µg/kg/minute
Treatment: Group I: Patients will receive norepinephrine <0.15 µg/kg/min
- Group IITreatment being tested
Patients will receive norepinephrine ≥ 0.15 µg/kg/minutes
Treatment: Group II: Patients will receive norepinephrine ≥ 0.15 µg/kg/min
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Different Norepinephrine Doses on Accuracy of Peripheral Perfusion Index in Predicting Tissue Perfusion in Septic Shock Patients
- Record updated
- 9 January 2026